Suppr超能文献

心脏淀粉样变性中的心内血栓形成与抗凝治疗

Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis.

作者信息

Feng DaLi, Syed Imran S, Martinez Matthew, Oh Jae K, Jaffe Allan S, Grogan Martha, Edwards William D, Gertz Morie A, Klarich Kyle W

机构信息

Metropolitan Heart and Vascular Institute, Minneapolis, Minn, USA.

出版信息

Circulation. 2009 May 12;119(18):2490-7. doi: 10.1161/CIRCULATIONAHA.108.785014. Epub 2009 May 4.

Abstract

BACKGROUND

Primary amyloidosis has a poor prognosis as a result of frequent cardiac involvement. We recently reported a high prevalence of intracardiac thrombus in cardiac amyloid patients at autopsy. However, neither the prevalence nor the effect of anticoagulation on intracardiac thrombus has been evaluated antemortem.

METHODS AND RESULTS

We studied all transthoracic and transesophageal echocardiograms of cardiac amyloid patients at the Mayo Clinic. The prevalence of intracardiac thrombosis, clinical and transthoracic/transesophageal echocardiographic risks for intracardiac thrombosis, and effect of anticoagulation were investigated. We identified 156 patients with cardiac amyloidosis who underwent transesophageal echocardiograms. Amyloidosis was the primary type (AL) in 80; other types occurred in 76 patients, including 56 with the wild transthyretin type, 17 with the mutant transthyretin type, and 3 with the secondary type. Fifth-eight intracardiac thrombi were identified in 42 patients (27%). AL amyloid had more frequent intracardiac thrombus than the other types (35% versus 18%; P=0.02), although the AL patients were younger and had less atrial fibrillation. Multivariate analysis showed that atrial fibrillation, poor left ventricular diastolic function, and lower left atrial appendage emptying velocity were independently associated with increased risk for intracardiac thrombosis, whereas anticoagulation was associated with a significantly decreased risk (odds ratio, 0.09; 95% CI, 0.01 to 0.51; P<0.006).

CONCLUSIONS

Intracardiac thrombosis occurs frequently in cardiac amyloid patients, especially in the AL type and in those with atrial fibrillation. Risk for thrombosis increased if left ventricular diastolic dysfunction and atrial mechanical dysfunction were present. Anticoagulation therapy appears protective. Timely screening in high-risk patients may allow early detection of intracardiac thrombus. Anticoagulation should be carefully considered.

摘要

背景

原发性淀粉样变性因心脏受累频繁,预后较差。我们最近报告了心脏淀粉样变性患者尸检时心内血栓的高发生率。然而,生前尚未评估心内血栓的发生率及抗凝治疗对其的影响。

方法与结果

我们研究了梅奥诊所心脏淀粉样变性患者的所有经胸和经食管超声心动图。调查心内血栓形成的发生率、心内血栓形成的临床及经胸/经食管超声心动图风险因素以及抗凝治疗的效果。我们确定了156例接受经食管超声心动图检查的心脏淀粉样变性患者。80例患者为原发性(AL)淀粉样变性;其他类型在76例患者中出现,包括56例野生型转甲状腺素蛋白型、17例突变型转甲状腺素蛋白型和3例继发性淀粉样变性。42例患者(27%)发现有58个心内血栓。AL淀粉样变性患者的心内血栓比其他类型更常见(35%对18%;P=0.02),尽管AL患者更年轻且房颤发生率更低。多因素分析显示,房颤、左心室舒张功能不全和左心耳排空速度降低与心内血栓形成风险增加独立相关,而抗凝治疗与风险显著降低相关(比值比,0.09;95%可信区间,0.01至0.51;P<0.006)。

结论

心脏淀粉样变性患者心内血栓形成频繁,尤其是AL型及合并房颤者。存在左心室舒张功能不全和心房机械功能不全时血栓形成风险增加。抗凝治疗似乎具有保护作用。对高危患者进行及时筛查可能有助于早期发现心内血栓。应谨慎考虑抗凝治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验